MedTrace Logo

Telemedicine in Age-Related Macular Degeneration

NCT04863391 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2021-04-28

No results posted yet for this study

Summary

This study seeks to evaluate a system for the automated early detection of Age-Related Macular Degeneration (AMD). AMD is a condition in which there is breakdown of the macula of the eye, the part of the retina that is responsible for sharp, central vision. We will take pictures of subjects' eyes using an automated camera. These photographs will be securely transmitted and and then analyzed by a computer program which has been developed in other studies. The outcome of the computer program analysis will be compared with human analysis of these same pictures. If the computer analysis is has good enough accuracy, then this computer system could be used for wide-scale screening for AMD.

Conditions

  • Age Related Macular Degeneration

Interventions

DIAGNOSTIC_TEST

Referrable versus Non Referral AMD diagnostic test

Artificial intelligence read reports Referrable versus Non Referral AMD

Sponsors & Collaborators

  • iHealthScreen Inc

    collaborator INDUSTRY

  • The New York Eye & Ear Infirmary

    lead OTHER

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-07-19
Primary Completion
2022-07-19
Completion
2022-12-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04863391 on ClinicalTrials.gov